These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 20501942)

  • 1. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.
    Ito Y; Teitelbaum SL; Zou W; Zheng Y; Johnson JF; Chappel J; Ross FP; Zhao H
    J Clin Invest; 2010 Jun; 120(6):1981-93. PubMed ID: 20501942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
    Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
    Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
    Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cytoplasmic Dynein Associated Protein NDE1 Regulates Osteoclastogenesis by Modulating M-CSF and RANKL Signaling Pathways.
    Das BK; Gogoi J; Kannan A; Gao L; Xing W; Mohan S; Zhao H
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
    Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
    J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-GEF trio regulates osteoclast differentiation and function by Rac1/Cdc42.
    Gu J; Yang Z; Yuan L; Guo S; Wang D; Zhao N; Meng L; Liu H; Chen W; Ma J
    Exp Cell Res; 2020 Nov; 396(1):112265. PubMed ID: 32898553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid Lineage Ablation of
    Karkache IY; Damodaran JR; Molstad DHH; Mansky KC; Bradley EW
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of ephrin B1 in cells of myeloid lineage increases osteoclast differentiation and bone resorption in mice.
    Cheng S; Zhao SL; Nelson B; Kesavan C; Qin X; Wergedal J; Mohan S; Xing W
    PLoS One; 2012; 7(3):e32887. PubMed ID: 22403721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G Protein-Coupled Receptor 120 Signaling Negatively Regulates Osteoclast Differentiation, Survival, and Function.
    Kim HJ; Yoon HJ; Kim BK; Kang WY; Seong SJ; Lim MS; Kim SY; Yoon YR
    J Cell Physiol; 2016 Apr; 231(4):844-51. PubMed ID: 26280807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins.
    Yeo CE; Kang WY; Seong SJ; Cho S; Lee HW; Yoon YR; Kim HJ
    Exp Cell Res; 2017 Oct; 359(1):112-119. PubMed ID: 28780306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-rich repeat kinase-1 regulates osteoclast function by modulating RAC1/Cdc42 Small GTPase phosphorylation and activation.
    Zeng C; Goodluck H; Qin X; Liu B; Mohan S; Xing W
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E772-E780. PubMed ID: 27600824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway.
    Lee YD; Kim B; Jung S; Kim H; Kim MK; Kwon JO; Song MK; Lee ZH; Kim HH
    Exp Mol Med; 2020 Mar; 52(3):514-528. PubMed ID: 32210358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts.
    Sakai H; Chen Y; Itokawa T; Yu KP; Zhu ML; Insogna K
    Bone; 2006 Dec; 39(6):1290-301. PubMed ID: 16950670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.